|
Mechanism50S subunit inhibitors |
|
|
|
Inactive Indication- |
Drug Highest PhaseApproved |
First Approval Ctry. / Loc.United States |
First Approval Date01 Jun 1951 |
100 Clinical Results associated with Alliance Boots GmbH
0 Patents (Medical) associated with Alliance Boots GmbH
100 Deals associated with Alliance Boots GmbH
100 Translational Medicine associated with Alliance Boots GmbH